Part, Chapter, Paragraph
1 II, 5. 11. 3| diseases in Europe Eur J Dermatol 2006;16:212-218~ ~ ~Table
2 II, 5. 11. 7| clinicopathological characteristics. J Dermatol 2003;30:123–131.~ ~Dalgard
3 II, 5. 11. 7| population surveys. Br J Dermatol 2003;149:794-800.~ ~de Rijke
4 II, 5. 11. 7| epidemiology of skin cancer. Br J Dermatol 2002;146(S61):1-6.~ ~Ferlay
5 II, 5. 11. 7| European survey. J Eur Acad Dermatol Venereol 2005;19(S3):2-6.~ ~
6 II, 5. 11. 7| Psoriasis: epidemiology. Clin Dermatol 2007;25:535-546.~ ~Hay R (
7 II, 5. 11. 7| Onychomycosis. J Eur Acad Dermatol Venereol. 2005;19 (S1):1-
8 II, 5. 11. 7| hospital-based assessment. Br J Dermatol 1994;131(S44):34.~ ~Johnson
9 II, 5. 11. 7| general population. J Am Acad Dermatol 1994;30:35-9.~ ~Larsson-Stymne
10 II, 5. 11. 7| possible ethnic variation. Br J Dermatol 1995;132:772-7.~ ~National
11 II, 5. 11. 7| hand-eczema survey. Br J Dermatol 2004;151(2):446-51.~ ~Verboom
12 II, 5. 11. 7| international comparison. Br J Dermatol 2002;147:716-24.~ ~Wassberg
13 II, 5. 11. 7| onychomycosis in Britain. Br J Dermatol 1993;129:101-109.~ ~Williams
14 II, 5. 11. 7| atopic dermatitis. Br J Dermatol (1994b):131:383-96.~ ~Williams
15 II, 5. 11. 7| atopic dermatitis. J Am Acad Dermatol 1995;32:212-217.~ ~Williams
16 II, 5. 11. 7| diseases in Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
17 III, 10. 1. 3| Confounding and interaction. Arch Dermatol 136(12):1544-6.~Szklo M,
